Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells.
Mol Cell Endocrinol
; 537: 111425, 2021 11 01.
Article
in En
| MEDLINE
| ID: mdl-34391847
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glucose Intolerance
/
Diabetes Mellitus, Type 2
/
Glucagon-Secreting Cells
/
Histone Acetyltransferases
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Mol Cell Endocrinol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: